Issues with recruitment to randomised controlled trials in the drug and alcohol field: A literature review and Australian case study

Drug and Alcohol Review

Volumn 27, Issue 2, 2008, Pages 115-122

  Thomson, Clare L ^a   Morley, Kirsten C ^a,b,c   Teesson, Maree ^a,c   Sannibale, Claudia ^a,c   Haber, Paul S ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

alcohol dependence; clinical trial; pharmacotherapy; placebo; recruitment; treatment

Indexed keywords

ADDICTION; AUSTRALIA; DRUG THERAPY; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN RELATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; DRUG THERAPY; HUMANS; PATIENT SELECTION; PROFESSIONAL-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 38949155133     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701829561     Document Type: Review

References (38)

1. Morley KC, Teesson M, Reid SC, et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 2006;101:1451-62.
2. Ashery RS, McAuliffe WE. Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse 1992;18:305-29.
3. Cottier LB, Compton WM, Ben-Abdallah A, et al. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend 1996;41: 209-17.
4. Latt NC, Jurd S, Houseman J, et al. Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Med J Aust 2002; 176: 530-4.
5. Shakeshaft AP, Bowman JA, Burrows S, et al. Community-based alcohol counselling: a randomized clinical trial. Addiction 2002;97:1449-63.
6. Feeney GF, Connor JP, Young RM, et al. Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status. Aust NZ J Psychiatry 2004;38:842-8.
7. Morris PL. Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 2001;96:1565-73.
8. Feeney GF, Young RM, Connor JP, et al. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved? Aust NZ J Psychiatry 2002;36:622-8.
9. Chick J, Howlett H, Morgan MY, et al. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 2000;35:176-87.
10. Rubio G, Jimenez-Arriero MA, Ponce G, et al. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol Alcohol 2001;36: 419-25.
11. Chick J, Anton R, Checinski K, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 2000;35:587-93.
12. Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 1997;92:1537-46.
13. Kranzler HR, Modesto-Lowe V, Van Kirk J. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 2000; 22:493-503.
14. Krystal JH, Cramer JA, Krol WF, et al. Naltrexone in the treatment of alcohol dependence [see comments]. New Engl J Med 2001;345:1734-9.
15. Mattick R, Digiusto E, Doran C, et al. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) : report of results and recommendations. Sydney: National Drug and Alcohol Research Centre, 2001.
16. Pich J, Carne X, Arnaiz J-A, et al. Role of a research committee in follow-up and publication of results. Lancet 2003;361:1015-16.
17. Easterbrook PJ, Matthews DR. Fate of research studies. J R Soc Med 1992;85:71-6.
18. Jaskiw GE, Blumer TE, Gutierrez-Esteinou R, et al. Comparison of inpatients with major mental illness who do and do not consent to low-risk research. Psychiatry Res 2003;119:183-8.
19. Ross S, Grant A, Counsell C, et al. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143-56.
20. Bale RN, Van Stone WW, Kuldau JM, et al. Therapeutic communities vs methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up. Arch Gen Psychiatry 1980;37: 179-93.
21. Proudfoot H, Teesson M. Who seeks treatment for alcohol dependence? Findings from the Australian National Survey of Mental Health and Wellbeing. Soc Psychiatry Psychiatr Epidemiol 2002;37:451-6.
22. McKeganey N. To pay or not to pay: respondents' motivation for participating in research. Addiction 2001;96: 1237-38.
23. Koocher GP. Questionable methods in alcoholism research. J Consult Clin Psychol 1991;59:246-8.
24. Bentley JP, Thacker PG. The influence of risk and monetary payment on the research participation decision making process. J Med Ethics 2004;30:293-8.
25. Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999;341:198-203.
26. Cunningham JA, Breslin FC. Only one in three people with alcohol abuse or dependence ever seek treatment. Addict Behav 2004;29:221-3.
27. Commander MJ, Odell SO, Williams KJ, et al. Pathways to care for alcohol use disorders. J Public Health Med 1999; 21:65-9.
28. Isenhart CE, Van Krevelen S. Relationship between readiness for and processes of change in a sample of alcohol dependent males. J Subst Abuse 1998;10:175-84.
29. Brooker C, Peters J, McCabe C, et al. The views of nurses to the conduct of a randomised controlled trial of problem drinkers in an accident and emergency department. Int J Nurs Stud 1999;36:33-9.
30. Rojavin MA. Recruitment index as a measure of patient recruitment activity in clinical trials. Contemp Clin Trials 2005;26:552-6.
31. Dickinson CJ. Clinical research in the NHS today. J R Coll Physicians Lond 1994;28:460-3.
32. Peto V, Coulter A, Bond A. Factors affecting general practitioners' recruitment of patients into a prospective study. Fam Pract 1993;10:207-11.
33. Richardson A, Sutherland M, Wells E, et al. Factors affecting general practitioner involvement in a randomised controlled trial in primary care. NZ Med J 2002;115: 153-5.
34. Bell-Syer SE, Klaber Moffett JA. Recruiting patients to randomized trials in primary care: principles and case studies. Fam Pract 2000;17:187-91.
35. Roche AM, Parle MD, Stubbs JM, et al. Management and treatment efficacy of drug and alcohol problems: what do doctors believe? Addiction 1995;90:1357-66.
36. Roche AM, Freeman T. Brief interventions: good in theory but weak in practice. Drug Alcohol Rev 2004;23:11-18.
37. Andreasson S, Parmander M, Allebeck P. A trial that failed, and the reasons why: comparing the Minnesota model with outpatient treatment and non-treatment for alcohol disorders. Scand J Soc Med 1990;18:221-4.
38. Hunt CJ, Shepherd LM, Andrews G. Do doctors know best? Comments on a failed trial. Med J Aust 2001; 174:144-6.